JP2023552292A5 - - Google Patents
Info
- Publication number
- JP2023552292A5 JP2023552292A5 JP2023530171A JP2023530171A JP2023552292A5 JP 2023552292 A5 JP2023552292 A5 JP 2023552292A5 JP 2023530171 A JP2023530171 A JP 2023530171A JP 2023530171 A JP2023530171 A JP 2023530171A JP 2023552292 A5 JP2023552292 A5 JP 2023552292A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- group
- nitrogen
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063116025P | 2020-11-19 | 2020-11-19 | |
| US63/116,025 | 2020-11-19 | ||
| PCT/US2021/059957 WO2022109179A1 (en) | 2020-11-19 | 2021-11-18 | Beta adrenergic agonist and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552292A JP2023552292A (ja) | 2023-12-15 |
| JP2023552292A5 true JP2023552292A5 (cg-RX-API-DMAC7.html) | 2024-10-31 |
Family
ID=81709821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530171A Pending JP2023552292A (ja) | 2020-11-19 | 2021-11-18 | βアドレナリンアゴニスト及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240352002A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4247348A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023552292A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230116775A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116528856A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021381373A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3196167A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023005821A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022109179A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024200780A1 (en) * | 2023-03-29 | 2024-10-03 | Atrogi Ab | Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3953463A (en) * | 1974-03-06 | 1976-04-27 | The United States Of America As Represented By The Secretary Of The Army | 2-Aryl-6-trifluoromethyl-4-pyridyl-carbinolamine antimalarials |
| US6831081B2 (en) * | 2002-09-04 | 2004-12-14 | Pharmacia & Upjohn | 4-Oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents |
| WO2017197324A1 (en) * | 2016-05-13 | 2017-11-16 | The Board Of Trustees Of The Leland Stanford Junior University | Adrenergic receptor modulating compounds and methods of using the same |
| CN108794452B (zh) * | 2017-05-05 | 2021-05-28 | 上海时莱生物技术有限公司 | 具有激酶抑制活性的化合物、其制备方法和用途 |
| GB201714740D0 (en) * | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| EP3628669A1 (en) * | 2018-09-28 | 2020-04-01 | GenKyoTex Suisse SA | Novel compounds as nadph oxidase inhibitors |
| GB201903832D0 (en) * | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
| JP7682097B2 (ja) * | 2019-03-27 | 2025-05-23 | キュラセン セラピューティクス インコーポレイテッド | ベータアドレナリンアゴニスト及びそれを使用する方法 |
-
2021
- 2021-11-18 EP EP21895614.2A patent/EP4247348A4/en active Pending
- 2021-11-18 JP JP2023530171A patent/JP2023552292A/ja active Pending
- 2021-11-18 US US18/035,262 patent/US20240352002A1/en active Pending
- 2021-11-18 CN CN202180077319.2A patent/CN116528856A/zh active Pending
- 2021-11-18 WO PCT/US2021/059957 patent/WO2022109179A1/en not_active Ceased
- 2021-11-18 CA CA3196167A patent/CA3196167A1/en active Pending
- 2021-11-18 AU AU2021381373A patent/AU2021381373A1/en active Pending
- 2021-11-18 KR KR1020237015739A patent/KR20230116775A/ko active Pending
- 2021-11-18 MX MX2023005821A patent/MX2023005821A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527769A5 (cg-RX-API-DMAC7.html) | ||
| DK2928885T3 (en) | MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR-GAMMA) FOR USE IN TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES | |
| JP6843114B2 (ja) | ムスカリン作動薬 | |
| WO2013138753A1 (en) | Prodrugs of riluzole and their method of use | |
| WO2016140878A9 (en) | Prodrugs riluzole and their method of use | |
| FR2719311A1 (fr) | Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. | |
| IL202405A (en) | Cycloalkylamines preserved in phenyl, a pharmaceutical compound containing it and its use in the preparation of a drug | |
| JP2021528427A5 (cg-RX-API-DMAC7.html) | ||
| KR20080071562A (ko) | ２-아미노벤즈아미드 유도체 | |
| JP2023552292A5 (cg-RX-API-DMAC7.html) | ||
| PE20251236A1 (es) | Formas cristalinas y sales de un agonista del receptor muscarinico | |
| WO2009089659A1 (en) | Pyrollidine-based compounds | |
| JP2023507569A5 (cg-RX-API-DMAC7.html) | ||
| EA031614B1 (ru) | Трициклические атропоизомерные соединения | |
| CN1142827A (zh) | Hiv蛋白酶抑制剂 | |
| JP2010509334A5 (cg-RX-API-DMAC7.html) | ||
| JP2002526527A (ja) | タキキニン受容体拮抗剤としてのナフタレンカルボキシアミド | |
| JP4704643B2 (ja) | ヘテロアリールオキシプロパノールアミン、その製造方法及びそれらを含有する医薬組成物 | |
| WO2023141595A2 (en) | Functionalized alkylamines | |
| US8703947B2 (en) | Compounds for treatment of Alzheimer's disease | |
| JP2023541375A5 (cg-RX-API-DMAC7.html) | ||
| CN1183778A (zh) | 喹啉羧酸衍生物 | |
| CN1083425C (zh) | 由环氧化物制备顺式－1－氨基－2－链烷醇的区域专一性方法 | |
| JP2019535715A5 (cg-RX-API-DMAC7.html) | ||
| JP2024536815A5 (cg-RX-API-DMAC7.html) |